On January 24 and 25, 2025, the LaserBlood team attended the International Symposium of the CRC1066 “Nanomaterials for Tumor Immunotherapy” in Mainz, Germany. This prestigious event brought together researchers and experts to discuss cutting-edge advancements in nanomaterials and their applications in cancer immunotherapy.
A highlight of the event was a presentation by a member of one of the LaserBlood project partners, titled “Therapeutic and Diagnostic Promises at the Nanoparticle-Protein Corona Interface”. The talk explored the potential of leveraging the nanoparticle-protein corona for innovative diagnostic and therapeutic solutions, a concept closely aligned with the LaserBlood project’s goals for early pancreatic cancer detection.
The event fostered a collaborative and dynamic atmosphere, with engaging presentations and lively networking opportunities. It was an inspiring gathering, offering valuable insights into emerging trends in cancer research and enabling new connections with leaders in nanomedicine and tumor immunotherapy.